About US
Contact us
-
With Boehringer ruling, industry extends legal losing streak against Medicare price negotiationsAs the process surrounding Medicare's drug price negotiations rolls on this summer—and as the pharmaceutical industry continues to loudly voice its complaints—another lawsuit contesting the legal via2024/6/27
-
China-made injectable PD-L1 drug flunks pivotal trial, forcing US partner to seek strategic optionsThe world’s first injectable immune checkpoint inhibitor likely won’t make it to the U.S. anytime soon after the China-approved drug flunked a pivotal trial in a rare cancer, forcing its stateside de2024/6/27
-
Emergent BioSolutions bags $250M in contract modifications to help boost US supply of medical countermeasuresWith four contract modifications totaling more than $250 million, the government is leveling up its agreements with long-time medical countermeasures supplier Emergent BioSolutions. The U.S. Departme2024/6/25
-
BIOSECURE Act hurts US biopharma industry's confidence in Chinese partners: surveyEven as theBIOSECURE Act charts an uncertain path through the legislative process, the draft bill has already seriously harmed the U.S. biopharma industry's perception of Chinese partners. Among U.S.2024/6/25
-
Biden joins Sanders' campaign targeting Novo Nordisk, Eli Lilly's diabetes and obesity drug pricesIn recent months, frequent pharma critic Sen. Bernie Sanders has beenratcheting up a campaignagainst Novo Nordisk over the price of its popular diabetes and weight loss medicines. Now, the senator ha2024/6/20
-
US FTC ramps up patent crusade with investigation into Teva's inhaler IP: reportWhile certain other drugmakers have relented in the face of the U.S. Federal Trade Commission’s (FTC’s) assault on alleged “junk” patents in the FDA’s Orange Book, Teva has largely stood its ground.2024/6/20
-
J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myelomaIn a major win for Johnson & Johnson and Legend Biotech, their star CAR-T therapy Carvykti showed it can prolong the lives of patients with previously treated multiple myeloma. J&J and Legend2024/6/18
-
After Gilead and J&J lawsuits, distributor Safe Chain sees its owners charged in criminal indictmentIn yet another legal development surrounding counterfeit HIVdrugs, a Florida court has handed down an indictment for the owners of a wholesale distributor that allegedly bought and redistributed $902024/6/18
-
Sun Pharma brightens up Ilumya promos with psoriasis campaign encouraging self-loveWhile many campaigns for plaque psoriasis treatments focus on erasing the external effects of the condition, Sun Pharma’s latest Ilumya push is emphasizing the importance of looking inward, too. The2024/6/13
-
Lilly touts fibrosis win as it pads case for tirzepatide in MASHBack in February, Eli Lilly teased “clinically meaningful” results around the ability of its dual GLP-1/GIP med tirzepatide to curb fibrosis in patients with fatty liver disease. Now, the company is2024/6/13